Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?

References

• AgenoWSquizzatoAGarciaDImbertiDEpidemiology and risk factors of venous thromboembolismSemin Thromb Hemost200632765165817024592
   PubMed Web of Science ®Google Scholar
• DragomanMVTepperNKFuRCurtisKMChouRGaffieldMEA systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraceptionInt J Gynaecol Obstet2018141328729429388678
   PubMed Web of Science ®Google Scholar
• StegemanBHde BastosMRosendaalFRDifferent combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisBMJ2013347f529824030561
   PubMed Web of Science ®Google Scholar
• Committee on Gynecologic PracticeACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospire-none-containing oral contraceptive pillsObstet Gynecol201212051239124223090561
   PubMedGoogle Scholar
• McLeanKCushmanMVenous thromboembolism and stroke in pregnancyHematology Am Soc Hematol Educ Program20162016124325027913487
   PubMed Web of Science ®Google Scholar
• KrattenmacherRKnautheRParczykKWalkerAHilgenfeldtUFritzemeierKHEstrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effectsJ Steroid Biochem Mol Biol1994482–32072148142296
   PubMed Web of Science ®Google Scholar
• CagnacciAHormonal contraception: venous and arterial diseaseEur J Contracept Reprod Health Care201722319119928351175
   PubMed Web of Science ®Google Scholar
• FruzzettiFDe NegriFMoraleMActivation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrelEur J Contracept Reprod Health Care19994311311810574636
   PubMed Web of Science ®Google Scholar
• van Hylckama VliegAHelmerhorstFMVandenbrouckeJPDoggenCJRosendaalFRThe venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyBMJ2009339b292119679614
   PubMed Web of Science ®Google Scholar
• LidegaardØLøkkegaardESvendsenALAggerCHormonal contraception and risk of venous thromboembolism: national follow-up studyBMJ2009339b289019679613
   PubMed Web of Science ®Google Scholar
• Peragallo UrrutiaRCoeytauxRRMcBroomAJRisk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysisObstet Gynecol20131222 Pt 138038923969809
   PubMed Web of Science ®Google Scholar
• LidegaardØNielsenLHSkovlundCWSkjeldestadFELøkkegaardERisk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–2009BMJ2011343d642322027398
   PubMed Web of Science ®Google Scholar
• BöttigerLEBomanGEklundGWesterholmBOral contraceptives and thromboembolic disease: effects of lowering oestrogen contentLancet198018178109711016103437
   PubMed Web of Science ®Google Scholar
• LidegaardONielsenLHSkovlundCWLøkkegaardEVenous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10BMJ2012344e299022577198
   PubMed Web of Science ®Google Scholar
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyWorld Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone ContraceptionLancet19953468990157515827500748
   PubMed Web of Science ®Google Scholar
• JickHJickSSGurewichVMyersMWVasilakisCRisk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsLancet19953468990158915937500750
   PubMed Web of Science ®Google Scholar
• SpitzerWOLewisMAHeinemannLAThorogoodMMacRaeKDThird generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young WomenBMJ1996312702383888555935
   PubMed Web of Science ®Google Scholar
• TepperNKWhitemanMKMarchbanksPAJamesAHCurtisKMProgestin-only contraception and thromboembolism: a systematic reviewContraception201694667870027153743
   PubMed Web of Science ®Google Scholar
• GalloMFNandaKGrimesDASchulzKF20 mcg versus >20 mcg estrogen combined oral contraceptives for contraceptionCochrane Database Syst Rev20052CD003989
   Google Scholar
• KuhnzWGansauCMahlerMPharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiolArzneimittelforschung19934399669738240460
   PubMed Web of Science ®Google Scholar
• KuhlHPharmacology of estrogens and progestogens: influence of different routes of administrationClimacteric20058Suppl 1363
   PubMed Web of Science ®Google Scholar
• KuhnzWBlodeHZimmermannHPharmacokinetics of exogenous natural and synthetic estrogens and antiestrogensOettelMSchil-lingerEHandbook of Experimental Pharmacology, Estrogens and Antiestrogens IIBerlinSpringer Verlag1999261322
   Google Scholar
• DüsterbergBNishinoYPharmacokinetic and pharmacological features of oestradiol valerateMaturitas1982443153247169965
   PubMed Web of Science ®Google Scholar
• ZeunSLuMUddinAZeilerBMorrisonDBlodeHPharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogestEur J Contracept Reprod Health Care200914322123219565420
   PubMed Web of Science ®Google Scholar
• KuhlHAdverse effects of estrogen treatment: natural versus synthetic estrogensLippertTHMueckAOGinsburgJSex Steroids and the Cardiovascular SystemNew YorkThe Parthenon Publishing Group1996201221
   Google Scholar
• GrandiGXholliANapolitanoAPiacentiIBellafronteMCagnacciAProspective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiolContraception201490552953424962542
   PubMed Web of Science ®Google Scholar
• ConardJBasdevantAThomasJLCardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiolFertil Steril19956459579627589641
   PubMed Web of Science ®Google Scholar
• JungeWMellingerUParkeSSerraniMMetabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre studyClin Drug Investig2011318573584
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersIParkeSMellingerUSerraniMJungeWHemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrelDrugs R D201111215917021679006
   PubMedGoogle Scholar
• ÅgrenUMAnttilaMMäenpää-LiukkoKEffects of a mono-phasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolismEur J Contracept Reprod Health Care201116644445722066891
   PubMed Web of Science ®Google Scholar
• GaussemPAlhenc-GelasMThomasJLHaemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised studyThromb Haemost2011105356056721225090
   PubMed Web of Science ®Google Scholar
• RapsMRosendaalFBallieuxBResistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialJ Thromb Haemost201311585586123410231
   PubMed Web of Science ®Google Scholar
• DingerJDo MinhTHeinemannKImpact of estrogen type on cardiovascular safety of combined oral contraceptivesContraception201694432833927343748
   PubMed Web of Science ®Google Scholar
• HeinemannKFrankeCMoehnerSdo MinhTDingerJCardiovascular safety in users of different combined oral contraceptives – Final results from the INAS-SCORE study Abstract FC-03, Book of abstracts: 15th Congress of the European Society of Contraception and Reproductive HealthEur J Contracept Reprod Health Care2018231143
   Google Scholar
• DingerJBardenheuerKHeinemannKCardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral ContraceptivesContraception201489425326324576793
   PubMed Web of Science ®Google Scholar
• CushmanMEpidemiology and risk factors for venous thrombosisSemin Hematol2007442626917433897
   PubMed Web of Science ®Google Scholar